The
May 2021 issue is online and opens with a new edition of our
Global Tour D’Horizon. In this month’s leading
Editorial, I. Cassimjee et al. report about
Vascular Surgery in South Africa in 2021 (
read for free).
After that, an
Editorial Debate discusses the
Surgical Perspective on the recent Voyager PAD Trial: A. Vahl et al. challenge some aspects of the trial’s interpretation (
read for free), and receive a response by S. Debus and M. Nehler (
read for free) who represent the trial’s executive committee – a lot of food for thought!
The first
Editor’s choice paper, by Galyfos et al., provides a meta-analysis of
Clinical Outcomes after Transcarotid Revascularisation for ICA Stenosis. In almost 5000 procedures, the approach seemed generally safe but possibly associated with increased cerebrovascular events in symptomatic patients (
read for free).
The second
Editor’s choice paper, by Scali et al., investigates the
The Volume–Outcome Relationship After Open AAA Repair in the Endovascular Era in the ICVR. In this multinational registry, a centre minimum of about 15 open intact AAA repairs per year was associated with greatest mortality risk reduction (
read for free).
The last
Editor’s choice paper, by Leatherby et al., scrutinises the
Effect of Weekend Admission on Outcomes for Ruptured Abdominal Aortic Aneurysms in a systematic review. They observed that rAAA management on weekends was indeed associated with mortality, but acknowledged that lack of patient-level data precluded predefined adjustments for confounding factors (
read for free).
In addition, the May issue features two
EJVES Open Access papers: Mulay et al. investigated the
Effect of Type 2 Endoleaks on Survival After EVAR. Both, presence of and intervention for type 2 endoleak did not seem to affect overall survival, but subgroups might still benefit from active management (
read for free).
Comes with an invited commentary by
F. Bastos Gonçalves
And De Donato et al. present the
INDIAN Trial on Vacuum Assisted Thrombo-Aspiration for Acute Lower Limb Ischaemia. They comfirmed the Indigon vacuum-assisted thrombo-aspiration system was safe and effective, but follow-up was limited to one month (
read for free).
Comes with an invited commentary by
J.J. Earnshaw.
We hope you enjoy this new edition of our Journal that offers a thought provoking debate and new insights into the latest vascular research. A good way to start into early summer!
Florian Dick Martin Björck
Editor-in-Chief Senior Editor
If you are a subscriber to the EJVES and have stored your access credentials to your computer or mobile device, you can access the whole issue here or individual papers via the links below. If you normally access the journal via the journal link in the ESVS members’ area, please go to the ESVS site via this link.
(If you are a subscriber but have no electronic access installed, you can find help here to set your computer or mobile device up.)